Journal Article

DKFZ-2026-01257

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Fatty acid channelling into triglycerides and oxylipins drives ferroptosis resistance during oncogenic BRAF-induced senescence.

Hess, M. S. (First author)DKFZ* ; Al-Shami, K. (First author)DKFZ* ; Caballero, C. D.DKFZ* ; Haenlin, J.DKFZ* ; Chaves-Filho, A. B.DKFZ* ; Schlicker, L.DKFZ* ; Poeller, P.DKFZ* ; Vogel, F. C. E.DKFZ* ; Koltsaki, I.DKFZ* ; Gedik, D.DKFZ* ; Alonso, M. C.DKFZ* ; Walz, S. ; Ade, C. P. ; Eilers, M. ; Straub, B. K. ; Utikal, J. S.DKFZ* ; Meierjohann, S. ; Rosenfeldt, M. T. ; Snaebjörnsson, M. T.DKFZ* ; Schulze, A. (Last author)DKFZ*

2026
Springer Nature [London]

Abstract: Oncogene-induced senescence (OIS), a cellular programme initiated by activation of oncogenic signalling, provides a barrier to transformation and is accompanied by major reprogramming of cellular metabolism. We show here that induction of OIS by BRAFV600E expression in human diploid fibroblasts led to global changes in the cellular lipidome, characterised by a strong increase in triglycerides (TG) and a marked reduction in membrane phosphoglycerides carrying polyunsaturated fatty acids (PUFA) in their acyl-chains. Induction of BRAFV600E OIS resulted in a marked resistance towards lipid peroxidation and ferroptosis. Inhibition of TG synthesis by blocking diacylglycerol O-acyltransferase 1 (DGAT1) resulted in PUFA re-distribution to membrane lipids and increased ferroptosis sensitivity of senescent cells. Inhibition of DGAT also altered the senescence-associated secretory phenotype (SASP) and enhanced the secretion of oxylipins by BRAFV600E OIS cells. Combined blockade of DGAT1-dependent TG and COX2-dependent oxylipin synthesis fully restored ferroptosis sensitivity in BRAFV600E OIS cells. Together, these findings indicate that channelling of PUFA towards TG synthesis confers protection from oxidative stress and ferroptosis during BRAFV600E OIS but also limits the production of pro-inflammatory lipid mediators, a key feature of the senescent phenotype.

Note: #EA:A410#LA:A410# / epub

---

Contributing Institute(s):

1. Personalisierte Medizinische Onkologie (A420)
2. KKE Dermatoonkologie (A370)

Research Program(s):

1. 311 - Zellbiologie und Tumorbiologie (POF4-311) (POF4-311)

Appears in the scientific report 2026

---

Database coverage:
; ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---